ReposiTrak, Inc.

The specific proposals to be considered and acted upon at our Annual Meeting were summarized in the Notice and are described in more detail throughout this Proxy Statement. As of September 25, 2026 (the “Record Date”), we had 18,201,204 shares of our common stock, par value $0.01 per share (“Common Stock”), outstanding, and 160,865 shares of our Series B Convertible Preferred Stock, par value $0.01 per share (“Series B Preferred”), outstanding, each of which are entitled to vote at the Annual Meeting. Each holder of Common Stock is entitled to one vote per share of Common Stock held, and each holder of Series B Preferred is entitled to 2.5 votes per share of Series B Preferred held as the Record Date. As of the Record Date, outstanding shares represented 18,603,163 votes, consisting of 18,201,204 attributable to Common Stock and 402,163 attributable to Series B Preferred.